Table 1 Characteristics of trial participants

Demographics

 Female sex, n (%)

4 (44)

 Age (years), median (IQR)

2 (1–3)

Facility, n (%)

 Suba

5 (56)

 Ahero

4 (44)

Vital signs at admission

 Temperature (axillary, °C), median (IQR)

37.3 (36.7–37.7)

  Fever (Tax > 37.5 °C), n (%)

4 (44)

 Respiratory rate (breaths/min), median (IQR)

38 (38–42)

  Tachypnea,^a n (%)

5 (56)

 Heart rate (beats/min), median (IQR)

136 (119–149)

  Tachycardia,^a n (%)

3 (33)

 Systolic blood pressure (mmHg), median (IQR)

95 (90–98)

  Hypotension, n (%)

0

 SpO₂ (% on room air),^b median (IQR)

80 (79–85)

  Hypoxemia (< 90%), n (%)

9 (100)

History of presenting illness, n (%)

 Cough

8 (89)

 Difficulty breathing

9 (100)

 Convulsions

1 (11)

 Not eating/drinking anything

1 (11)

Physical exam at admission

 Chest indrawing, n (%)

7 (78)

 Wheezing, n (%)

1 (11)

 Delayed capillary refill time (> 3 s), n (s)

0

 Altered consciousness, n (%)

0

 Composite clinical severity (SICK) score,^c median (IQR)

1.7 (1.7–1.9)

Diagnoses, n (%)

 Pneumonia

7 (78)

 Malaria

3 (33)

 Other^d

3 (33)

MPR utilization, n (%)

 Patient finished O₂ treatment with MPR

5 (56)

 MPR stopped early, switch to O₂ cylinder

4 (44)

Outcome, n (%)

 Discharged home

5 (56)

 Transferred to another facility

3 (33)

Fatal

1 (11)